Takeda launches Cinryze in India for prophylaxis in hereditary angioedema patients
Cinryze is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.